Diagnostic approaches for oculoglandular tularemia: Advantages of PCR

British Journal of Ophthalmology

Volumn 91, Issue 9, 2007, Pages 1206-1208

  Kantardjiev, Todor ^a   Padeshki, Plamen ^a   Ivanov, Ivan N ^a  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ARTICLE; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; EYE INFECTION; HUMAN; OCULOGLANDULAR TULAREMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CONJUNCTIVA; DNA, BACTERIAL; EYE INFECTIONS, BACTERIAL; FRANCISELLA TULARENSIS; HUMANS; OCULAR MOTILITY DISORDERS; POLYMERASE CHAIN REACTION; TULAREMIA;

EID: 34548297195     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.117523     Document Type: Article

References (18)

1. Dennis D, Inglesby T, Henderson D, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73.
2. Kantardjiev T, Velinov T. Interaction between protozoa and microorganisms of the genus Franacisella. Problems of Infectious Diseases 1995;22:34-5.
3. Sjostedt A. Family XVII. Francisellaceae, genus I. Francisella. In: Brenner DJ, ed, Bergey's manual of systematic bacteriology. New York, NY:Springer, 2003:111-35.
4. Sandstrom G, Sjostedt A, Forsman M, et al. Characterization and classification of strains of Francisella tularensis isolated in the Central Asian focus of the Soviet Union and Japan. J Clin Microbiol 1992;30:172-5.
5. Staples JE, Kubota KA, Chalcraft LG, et al. Epidemiologic and Molecular Analysis of Human Tularemia, United States, 1964-2004. Emerg Infect Dis 2006;7:1113-18.
6. Kantardjiev T, Ivanov I, Velinov T, et al. Tularemia outbreak, Bulgaria, 1997-2005. Emerg Infect Dis 2006;4:678-80.
7. Fortier A. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser 1994;60:349-61.
8. Steinemann TL, Sheikholeslami MR, Brown HH, et al. Oculoglandular tularemia. Arch Ophthalmol 1999;117:132-3.
9. Starck T, Madsen BW. Positive polymerase chain reaction and histology with borderline serology in Parinaud's oculoglandular syndrome. Cornea 2002;6:625-7.
10. Centers for Disease Control and Prevention Division of Public Health Surveillance and Informatics. Available from http://www.cdc.gov/epo/dphsi/ casedef/tularemia_current.htm (accessed 20 February 2000).
11. Bevanger L, Maeland J, Naess A. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of diseases during an outbreak of tularemia. J Clin Microbiol 1988;26:433-7.
12. Olsufjev N, Tularemia. Methods for laboratory diagnostics of tularemia. In: Olsufjev N, eds. Diagnostics of infections at high medical risk. Rostow University, 1970:170-9.
13. Ausbel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology, John Wiley and Sons, 1995:2.4.1.
14. Johansson A, Berglund L, Eriksson U, et al. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 2000;38:22-6.
15. Broekhuijsen M, Larsson P, Johanssonsen A, et al. Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within species but identifies regions that are unique to the highly virulent F. tulatensis subsp. tularensis. J Clin Microb 2003;41:2924-31.
16. Vassileva P, Petrow P, Kantardjiev T, et al. Tularemia: first cases of oculoglandular form of the disease in Bulgaria. Comptes Rendus - Academie Bulgare des Sciences 2003;56:117-20.
17. Alberts B, Liebowitz H. Guide for the care and use of laboratory animals. Washington, DC: Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council, National Academy Press, 1996.
18. Martin GJ, Marty AM. Clinicopathologic aspects of bacterial agents. Clin Lab Med 2001;221:513-48.